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Studies on the Reaction Mechanism of Riboflavin
Synthase: X-Ray Crystal Structure of a Complex
with 6-Carboxyethyl-7-Oxo-8-Ribityllumazine
scribed recently [8]; riboflavin synthase can convert that
compound into riboflavin and the pyrimidine derivative
7 (forward reaction) as well as into 6,7-dimethyl-8-ribityl-
lumazine (backward reaction).
Riboflavin synthases are characterized by an internal
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Gram-negative bacteria and certain yeasts are unable
to incorporate riboflavin from the environment and are
therefore absolutely dependent on endogenous synthe-Summary
sis of the vitamin [19–22]. Riboflavin synthase is there-
fore a potential target for the development of anti-infec-Riboflavin synthase catalyzes the disproportionation
of 6,7-dimethyl-8-ribityllumazine affording riboflavin tive drugs. The design of specific enzyme inhibitors
could benefit substantially from protein structure infor-and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedi-
one. We have determined the structure of riboflavin mation.
The structure of riboflavin synthase from Escherichiasynthase from Schizosaccharomyces pombe in com-
plex with the substrate analog, 6-carboxyethyl-7-oxo- coli has been determined by X-ray crystallography at a
resolution of 2.1 A˚ [10], but the substrate binding deter-8-ribityllumazine at 2.1 A˚ resolution. In contrast to the
homotrimeric solution state of native riboflavin syn- minants and local structure of the active site have not
been elucidated unambiguously. This paper reports thethase, we found the enzyme to be monomeric in the
crystal structure. Structural comparison of the ribofla- structure of riboflavin synthase of Schizosaccharo-
myces pombe in complex with the substrate analog,vin synthases of S. pombe and Escherichia coli sug-
gests oligomer contact sites and delineates the catalytic 6-carboxyethyl-7-oxo-8-ribityllumazine (8; Figure 3).
site for dimerization of the substrate and subsequent
fragmentation of the pentacyclic intermediate. The Results
pentacyclic substrate dimer was modeled into the pro-
posed active site, and its stereochemical features Quality of the Model
Riboflavin synthase from S. pombe was crystallized inwere determined. The model suggests that the sub-
strate molecule at the C-terminal domain donates a complex with the bound substrate analog, 6-carboxy-
ethyl-7-oxo-8-ribityllumazine (8; Figure 3). Native dif-four-carbon unit to the substrate molecule bound at
the N-terminal domain of an adjacent subunit in the fraction data were collected to a resolution of 2.7 A˚.
The crystals belonged to space group P61, with oneoligomer.
monomer in the asymmetric unit. The crystal structure
in complex with 8 was solved by multiple anomalousIntroduction
dispersion techniques using synchrotron radiation. The
structure was refined to 2.1 A˚ resolution with crystallo-Riboflavin (vitamin B2) serves as a precursor of flavo-
coenzymes, which have essential roles as redox cofactors graphic R values of 18.5% (Rfree  22.0%) with good
stereochemistry (Table 1).in all organisms. The final step in the biosynthesis of the
vitamin is catalyzed by the enzyme riboflavin synthase The final model of monomeric S. pombe riboflavin
synthase (Figure 4A) consists of 203 residues that were[1–3]. This unusual reaction involves the dismutation of
6,7-dimethyl-8-ribityllumazine (1), affording riboflavin (6) well defined with the exception of the last 5 residues.
Most of the side chains were clearly defined by theirand 5-amino-6-ribitylamino-2,4(1H,3H )-pyrimidinedione
(7) (Figure 1) [4–7]. A pentacyclic intermediate of the en- electron density, except for some surface-exposed res-
idues.zyme-catalyzed reaction (4, compound Q) has been de-
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expression of the N-terminal domain of the E. coli protein
afforded a c2 symmetric homodimer [25, 26].
The monomeric S. pombe riboflavin synthase model
consists of 203 amino acids, arranged in an N-terminal
 barrel (residues 1–90), an almost identically folded
C  barrel (residues 91–184), and a C-terminal  helix
(residues 185–203) (Figure 4A). Superimposition of 168
-carbon atoms including both  barrels and the C-ter-
minal helix of the monomers of riboflavin synthase from
S. pombe and E. coli reflects their high structural similar-
ity by an rmsd value of 0.8 A˚ (Figure 6).
A structural comparison of the N-terminal  barrel and
the C  barrel of S. pombe riboflavin synthase (Figure
4B) shows their internal pseudo-2-fold symmetry with
an rmsd value of 0.97 A˚ for 84 -carbon atoms.
Binding of a Substrate Analog Inhibitor
to the  Barrel Domains
We cocrystallized riboflavin synthase from S. pombe
with a derivative of substrate 1, 6-carboxyethyl-7-oxo-
8-ribityllumazine (8). This tightly bound inhibitor mole-
cule is well defined in its electron density map at 2.1 A˚
resolution and clearly indicates the location of the two
substrate binding sites of each  barrel domain (Figure
5). By comparison of the two barrel domains, the posi-Figure 1. Hypothetical Reaction Mechanism of Riboflavin Synthase
tions of the bound substrate analog of each barrel are1a, donor lumazine molecule; 1b, acceptor lumazine; X, proposed
matched almost exactly (Figure 2B). The substrate ana-nucleophile, which neutralizes the carbonium centre at C-7 of 1b
logs are mainly bound through hydrophilic side chainand enables carbanion attack at C-6 of 2 by the 7-exomethylene
carbon of 1a [3, 30]; R, ribityl chain. and main chain interactions (Figures 3A and 3B). In con-
trast to the binding of 6-carboxyethyl-7-oxo-8-ribityllu-
mazine to 6,7-dimethyl-8-ribityllumazine synthase of S.
pombe [27], the upstream enzyme in the riboflavin syn-Crystal packing and the space group clearly show
thetic pathway, 8 is bound to S. pombe riboflavin syn-that the enzyme is present as a monomer in the crystals.
thase without contributions by aromatic stacking inter-Meanwhile, sedimentation studies had shown a trimer
actions.in solution (our unpublished data). The sedimentation
equilibrium experiments were performed with a protein
solution (0.7 mg/ml) containing 20 mM potassium phos-
6-Carboxyethyl-7-Oxo-8-Ribityllumazine Bindingphate (pH 7.0) and 100 mM potassium chloride. Notably,
to the N-Terminal Barrelthe trimer structure was also observed by sedimentation
The lumazine chromophore of 8 in the N-terminalbarrelequilibrium analysis in the presence of the inhibitor 8,
is exclusively involved in hydrophilic interactions (Figurewhich was used in the crystallization experiments. We
3A). The strictly conserved active site residue, His102,conclude that crystallization induces dissociation, prob-
the only aromatic residue in the N-terminal active site,ably as a result of the high amount of methylpentanediol
forms only a hydrogen bond by its side chain to thepresent.
oxo substituent at position 7 of the lumazine ring. TheThe temperature factors of bound 8 (23.0 A˚2 ) are lower
peptide amide groups of Ala64 and Thr50 are orientedthan those of the protein on average (27.2 A˚2 ) (Table 1).
toward the O2 and O4 carbonyl groups of the ligandCorrespondingly, the two ligand molecules were well
lumazine ring at distances of 2.7 A˚ and 2.9 A˚, respec-defined in the final electron density maps (Figure 5),
tively. In addition, the side chain oxygen atom of Thr50indicating clearly the proposed active site arrangements
is involved in a hydrogen-bonding interaction with theand allowing insights into the reaction mechanism of
imido group N5 of the ring system. The carbonyl oxygenriboflavin biosynthesis.
of Gly62 is strongly hydrogen bonded to the N3-imide
hydrogen atom of the CEOL inhibitor at a distance of
2.7 A˚. The side chain oxygen -O of Ser67 is involved inStructural Overview
Riboflavin synthases from E. coli and B. subtilis are both an additional hydrophilic interaction to the O2 carbonyl
group and further in a hydrogen bond interaction tohomotrimers in solution as shown by hydrodynamic
studies [23, 24]. The crystal structure of the ligand-free the OH3 hydroxyl group of the ribityl side chain of the
lumazine ring system. The next ribityl hydroxyl groupenzyme of E. coli has been reported [10]. The enzyme
is an asymmetric trimer with the subunits related to one OH4 is hydrogen bonded to the main chain amide group
of Val103. The residues Val103 and His102 take part inanother by rotations of 124, 85, and 151. Trimerization
occurs principally via the C-terminal helices, but does 8 binding from the following C barrel of the S. pombe
riboflavin synthase monomer. The distance between thenot lead to a symmetrical structure. The recombinant
Biosynthesis of Riboflavin Synthase
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Figure 2. Internal Sequence Alignment of Riboflavin Synthase
(A) Alignment of the N barrel (red) and the C barrel (blue) domains of S. pombe.
(B) Stereo diagram of an internal superposition of the two  barrels with bound 6-carboxyethyl-7-oxo-8-ribityllumazine.
thiol group of Cys48 and carbon atom 6 of 8 is 4.0 A˚ N-terminal barrel and establishes identical hydrogen
bonds. The carbonyl oxygen of Met160 is strongly hy-(Figure 3C).
drogen bonded to the N3-imide hydrogen atom of the
inhibitor at a distance of 2.7 A˚. Ser67 of the N-terminal6-Carboxyethyl-7-Oxo-8-Ribityllumazine Binding
to the C-Terminal Barrel barrel is replaced by the corresponding Thr165. In the
C-terminal barrel, Thr165 is hydrogen bonded to the O2The binding arrangement of 8 in the C  barrel is almost
the same as for the N-terminal barrel mentioned above carbonyl group. Corresponding to the N-terminal barrel,
the OH3 hydroxyl group of the ribityl side chain of the(Figure 3B). The two aromatic residues, Tyr139 and
Tyr164, interact with the bound ligand via hydrogen lumazine ligand is in hydrogen-bonding distance to the
-O atom of Thr165. Only the active site residue Val6 ofbonds to the carboxyethyl substituent at position 6 of
the lumazine derivative and its ribityl side chain, respec- the adjacent N-terminal barrel is involved with the main
chain amide group in a hydrogen contact to the ribityltively. The peptide amide groups of Ile162 and Thr148
are in hydrogen-bonding distance with the O2 and O4 hydroxyl group OH4 of the bound CEOL in the C barrel
of the S. pombe riboflavin synthase monomer. Whereascarbonyl groups of the ligand lumazine system. The ac-
tive site residue Thr148 of the C barrel is in the same most amino acid residues in direct contact with the
lumazine chromophore are identical at the N- and C-ter-topological position as the corresponding Thr50 of the
Structure
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Figure 3. Hydrogen-Bonding Topology of
6-Carboxyethyl-7-Oxo-8-Ribityllumazine (8)
Bound to S. pombe Riboflavin Synthase
N-terminal domain (A); C-terminal domain (B);
distances from the thiolate group of cysteine
48 (C); distances from the side chain oxygen
of serine 146 (D); compound Q (E).
minal binding sites, the amino acid topologically equiva- has been confirmed by X-ray structure analysis of ribo-
flavin synthase of E. coli (without bound ligand) [10] andlent to cysteine 48 of the N  barrel is the serine residue
146 of the N  barrel. of S. pombe (with bound ligand). In the crystals of the
S. pombe protein, the two folding domains are related
by a noncrystallographic pseudo-c2 symmetry axis withDiscussion
a rotation angle of 176.2 (Figure 4B).
Both domains of the S. pombe protein can bind oneThe benzenoid ring of riboflavin originates in a most
unusual way by dismutation of the pteridine derivative molecule of the enzyme inhibitor, 6-carboxyethyl-7-oxo-
8-ribityllumazine, in shallow cavities lined by hydrophilic1. The available information on the reaction mechanism
can be summarized as follows. (1) The enzyme-cata- groups. The conformations of the ligand molecules
bound to the N- and C-terminal domains are closelylyzed reaction requires no organic cofactors and no
metal ions [15]. (2) The reaction can proceed in the similar. The amino acid residues in contact with the
bound ligand are also closely similar. The major differ-absence of a catalyst in neutral or acidic aqueous solu-
tion [16–18]. (3) The pentacyclic lumazine dimer 4 fulfills ence is a cysteine residue (position 48 in the N-terminal
domain) being replaced by a serine residue (positionthe criteria for a kinetically competent reaction interme-
diate [8]. (4) The pentacyclic intermediate can be cleaved 146 in the C-terminal domain). Both amino acids are
absolutely conserved in all putative riboflavin synthaseby riboflavin synthase to yield either riboflavin (6) and the
pyrimidine 7 or two molecules of the riboflavin synthase paralogs. Nevertheless, serine 146 of the S. pombe en-
zyme can be replaced by alanine with only a minor im-substrate 1. (5) An isotope effect of 5.0 has been found
for [6-2 H3]6,7-dimethyl-8-ribityllumazine [5]. Hence, the pact on enzyme activity. Replacement of cysteine 48
by serine reduces the activity by a factor of five, butrelease of a proton(s) from the position 6 methyl group
could involve a relatively high energy barrier. replacement by alanine affords a soluble protein whose
activity, if any, is below the level of detection (our unpub-Riboflavin synthase of bacteria and yeasts, including
S. pombe, are homotrimeric proteins in solution. The lished data). It should also be noted that mutant genes
specifying E. coli riboflavin synthase mutants carryingquaternary structure of the S. pombe enzyme in solution
is not affected by the ligand 8, the ligand used in the alanine or serine instead of cysteine 48 (corresponding
to cysteine 48 of the S. pombe enzyme) could not bepresent crystallographic study (our unpublished data).
Hence, the monomer structure found in the crystals must expressed in recombinant E. coli strains [28]. Distances
of the side chain heteroatom of cysteine 48 and serinebe due to the crystallization buffer, most probably by
the organic solvent used as precipitant. 146 to atoms of the bound enzyme inhibitors are shown
in Figures 3C and 3D. The closest neighbor of the thiolThe riboflavin synthase subunit folds into two domains
with closely similar folding topology (0.97 A˚ rmsd in group is the 6-methylene group of the ligand (3.7 A˚).
The folding topologies of the E. coli and S. pombecase of the S. pombe enzyme; Figure 2). This had been
anticipated on the basis of sequence arguments [9] and enzymes are closely similar (Figure 6). Moreover, the
Biosynthesis of Riboflavin Synthase
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Table 1. X-Ray Data Processing and Refinement Statistics
DERI (Thiomersal) NATI
Cell constants (A˚)
a  b 70.50 70.32
c 92.95 92.37
Space group P61 P61
Resolution limit (A˚) 2.1 2.7
Reflections, unique 15,097 6,988
Remote Peak Edge
Wavelength (A˚) 0.94991 1.000 1.010
Multiplicitya 2.0 2.0 2.0 2.7
Rmergeb overall 0.097 0.098 0.101 0.127
Rmergea,c 0.265 0.302 0.314 0.348
Completeness overall (%) 94.5 94.5 93.1 97.8
Completeness (%)c 95.3 95.2 69.8 97.8
Reflectionsa 28,494 28,350 27,976
Completeness anomalous (%) 89.8 89.4 89.5
Nonhydrogen protein atoms 1,558 1,558
Solvent molecules 121 79
Nonhydrogen ligand atoms 54 54
Nonhydrogen ion atoms 1 —
Resolution range (A˚) 19.88–2.1 20.6–2.7
R value overall (%)d 18.5 19.8
Rfree (%) 22.0 26.3
Root mean standard deviations
Bond lengths (A˚) 0.006 0.007
Bond angles () 1.24 1.21





φ,  angle distribution for residuese
In most favored regions (%) 86.0 80.3
In additional allowed regions (%) 14.0 19.7
In generously allowed regions (%) 0.0 0.0
In disallowed regions (%) 0.0 0.0
a Friedel-Mates treated as independent reflections.
b Rmerge  hkl [(i|Ii  	I
|)/iIi]
c Values correspond to the highest resolution shell (Hg derivative, 2.14–2.1 A˚; native, 2.85–2.7 A˚).
d R value  hkl ||Fobs|  |Fcalc||/hkl|Fobs|
e Ramachandran statistics as defined by PROCHECK [43].
Rfree is the crossvalidation R factor computed for the test set of 10% of unique reflections.
amino acids in direct contact with the bound ligand are molecules are bound in different environments. Recent
NMR experiments with the S. pombe enzyme gave simi-identical or very similar in the E. coli enzyme (Figure 7).
Therefore, the lumazine analog could be modeled easily lar results (our unpublished data). We conclude that
the asymmetry observed with the unliganded E. colifrom the S. pombe structure to all six binding sites of
the E. coli enzyme (Figure 4C). riboflavin synthase persists in the presence of ligands.
The protein perturbation studies are well in line with theThe E. coli riboflavin synthase is devoid of trigonal
symmetry [10]. Trimerization occurs via the C-terminal hypothesis of major dynamic motions in the homotri-
meric protein which could bring N- and C-terminal do-helices. Only the N-terminal domain of one subunit has
extended contacts with the C barrel domain of a second mains of different subunits into the appropriate spatial
relationship for substrate dimerization. The crystalsubunit. Only in one out of three potential active sites,
two subunits are in close contact and form an active site structure of the E. coli enzyme would then have to be
interpreted as a snapshot of a specific conformationwith pseudo-c2 symmetry (Figure 8), where the substrate
molecules are ideally positioned for the dismutation re- which is stabilized by crystal contacts.
In order to analyze the reaction mechanism in closeraction.
Indirect evidence for the nonsymmetrical character of detail, we replaced the inhibitor molecules in Figure 9A
(1) by the substrate 6,7-dimethyl-8-ribityllumazine (Fig-riboflavin synthases had been obtained earlier by pro-
tein perturbation experiments using fluorinated pteri- ure 9B) and (2) by the pentacyclic reaction intermediate
4 (Figure 9C).dine derivatives which were monitored by 19F NMR [12,
13, 28, 29]. Multiple 19F NMR signals were observed for The stereochemistry of the pentacyclic intermediates
has not been determined hitherto. It appears plausibletrifluoromethyl groups of enzyme-bound ligands, which
were best explained by the hypothesis that the ligand that the dimerization of 6,7-dimethyl-8-ribityllumazine
Structure
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Figure 4. The S. pombe Riboflavin Synthase
Monomer and Proposed Trimer
Stereo diagrams of the S. pombe riboflavin
synthase monomer (A) with bound 6-car-
boxyethyl-7-oxo-8-ribityllumazine (yellow); a
view along the pseudo-2-fold symmetry axis
of the two folding domains (B); the trimeric
model of S. pombe riboflavin synthase (C)
with bound 6-carboxyethyl-7-oxo-8-ribityllu-
mazine (yellow).
should result in syn linkage of the ring systems of donor the N-terminal domain is the four-carbon acceptor and
the substrate bound to the C-terminal domain is themolecule 1a and receptor molecule 1b (Figure 1). Of the
two diastereomers (6*R;7*S) and (6*S;7*R), only (6*R;7*S) four-carbon donor.
With this in mind, the thiolate group of cysteine 48(Figure 3E) fits into the cavity formed at the interface of
the N- and C-terminal domains of subunits A and C of may act as a base which abstracts a proton from the
6-methylene group in the hypothetical reaction inter-the E. coli enzyme.
The result of a dynamics simulation described in Ex- mediate 4 and/or 5. However, it should be noted that
the catalytic activity of the enzyme is only reduced 6-foldperimental Procedures is shown in Figure 9C. The penta-
cyclic substrate dimer fits closely into the putative active by replacement of cysteine 48 with serine, although the
KA values of cysteine and serine differ by at least fivesite of S. pombe riboflavin synthase generated with the
coordinates of the E. coli enzyme [10]. Upon enzymatic orders of magnitude.
The serine residue 146 could act as the nucleophile Xcleavage of the dimer, the resulting riboflavin would be
bound to the N-terminal domain, and the pyrimidine proposed by Plaut and Beach [3]. However, it is also possi-
ble that this function could be assumed by a water mole-product would be bound to the C-terminal domain. In
other words, the lumazine molecule originally bound to cule, since the reaction can proceed without enzyme
Biosynthesis of Riboflavin Synthase
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Figure 5. Stereo Views of the Substrate Bind-
ing Site of Riboflavin Synthase from S. pombe
Comparison of 6-carboxyethyl-7-oxo-8-ribi-
tyllumazine binding to the N barrel ([A], red)
and C barrel ([B], blue). The refined 2Fo  Fc
electron density maps covering the bound
ligands are contoured at 1.0 .
catalysis. This would fit the observation that, although unit. Previous structural analysis [10] and NMR studies
(our unpublished data) [9, 23, 24] revealed a markedlyserine 146 appears to be absolutely conserved, it can
be replaced with only minor impact on catalytic rate. nonsymmetric trimeric state of riboflavin synthase. Our
modeling experiments, based on the inhibitor-boundPlaut and Beach proposed an elegant hypothesis sug-
gesting that the hydroxyl group of the position 8 ribityl protein, strongly suggest that the close intersubunit con-
tact of the trimer as seen in the crystals of the E. coliside chain of 2 could act as a nucleophile attacking
position 7 of the pteridine system under formation of a protein is indeed in an active conformation and capable
of supporting the dismutation reaction. Therefore, thistricyclic reaction intermediate [30]. Indeed, the forma-
tion of tricyclic lumazine anion structures has been trimer very likely represents a distinct functional state.
As there is no reason to suggest a static asymmetricshown in solution [31–33]. The X-ray structure of the S.
pombe enzyme shows the ribityl side chains of both ensemble, it appears likely that thermal fluctuation or
substrate binding converts the three different intersub-substrate molecules to be bound strongly in an ex-
tended conformation. This appears inconsistent with the unit contacts into one another, retaining an asymmetric
trimer.proposed tricyclic anion intermediate. On the contrary,
the polyol side chains of both substrate molecules are We demonstrate here that the reaction is achieved by
binding the substrate molecules in a pseudo-c2 symmet-likely to retain an extended conformation throughout
the complex reaction trajectory. ric environment, where the C-terminal domain acts as
donor site and the N-terminal domain as acceptor site.
In addition, the geometry of the active site allows us toBiological Implications
suggest the stereochemistry of the pentacyclic interme-
diate 4.Riboflavin synthase performs an unusual dismutation
reaction in which two identical substrate molecules The enzymes of the riboflavin biosynthetic pathway
are essential enzymes in enterobacteria or yeasts as aserve as donor (1a) or acceptor (1b) of a four-carbon
Figure 6. Structural Comparison
Stereo diagram of the superposition of one
subunit of riboflavin synthase from E. coli
(blue) and S. pombe (green).
Structure
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Figure 7. Structural Sequence Alignment of
Riboflavin Synthase from S. pombe and E. coli
The numbering above the alignment corre-
sponds to wild-type enzyme from S. pombe.
Red arrows indicate the residues involved in
6-carboxyethyl-7-oxo-8-ribityllumazine bind-
ing to the N-terminal  barrel. Blue arrows
indicate the residues involved in 6-carboxy-
ethyl-7-oxo-8-ribityllumazine binding to the
C-terminal  barrel of the S. pombe enzyme.
against a 0.3 ml reservoir solution containing 0.1 M bicine (pH 9.0)consequence of the apparent absence of a flavin uptake
and 65% (v/v) 2-methyl-2,4-pentanediol (MPD). Droplets were com-system. Therefore, riboflavin synthase itself is a potential
posed of 2 l enzyme solution (9 mg/ml of 20 mM Tris hydrochloridetarget for anti-infective drugs. The detailed analysis of
[pH 7.0], containing 100 mM potassium chloride and a 10 molar
the reaction mechanism could reveal new insights for excess of solid 8) and 2 l of reservoir buffer. For data collection,
the development of mechanism-based enzyme inhibi- these cocrystals could be frozen at 100 K in reservoir buffer serving
as a cryoprotectant due to its high content of MPD.tors designed for therapeutic application. The pseudo-
c2 symmetric active site allows the design of inhibitors
Data Collection and Structure Solutionthat link the donor and acceptor domains with a single
Native X-ray data (NATI) for the inhibitor-bound wild-type enzymeinhibitor as a novel strategy for inhibitor design [29].
were collected on a MAR Research 345 imaging plate detector
system mounted on a Rigaku RU-200 rotating anode operated at
Experimental Procedures
50 mA and 100 kV with   CuK  1.542 A˚ under cryogenic condi-
tions. The X-ray intensities were evaluated up to 2.7 A˚ by using the
Materials
MOSFLM [35] program package. The crystals complexed with 8
6-Carboxyethyl-7-oxo-8-ribityllumazine was prepared by published
belong to the space group P61 with cell constants a  b  70.32 A˚,procedures [34]. Recombinant riboflavin synthase of S. pombe was
c  92.37 A˚. The asymmetric unit contained one monomer resulting
prepared (our unpublished data).
in a Matthews coefficient of 3.0 A˚3 /Da [36] with a solvent content
of 59%.
Crystallization
Heavy atom derivatives were prepared by soaking the cocrystals
Crystals of S. pombe riboflavin synthase in complex with 6-carboxy-
at room temperature either in 2 mM thiomersal (C9H9HgNaO2S) forethyl-7-oxo-8-ribityllumazine of maximal dimensions 0.2 mm  0.05
2 hr or incubation with tantalum bromide (Ta6Br12) overnight. Themm 0.05 mm grew within a few days by sitting drop vapor diffusion
corresponding derivatives and double derivatives were analyzed by
difference Patterson methods and cross-phased difference Fourier
maps with MLPHARE [37].
Anomalous data (DERI) for MAD phasing were collected from a
single cross-phased characterized mercury heavy atom cocrystal
at the DESY synchrotron source beamline BW6 (Hamburg, Germany)
employing a MAR Research CCD detector. The derivatized cocrystal
was frozen at 100 K, with the mother liquor serving as a cryoprotec-
tant. The MAD data up to 2.1 A˚ were measured at Hg-K absorption
edges f (1.010 A˚) and f″ (1.000 A˚) and the remote wavelength at
0.9499 A˚. Complete data sets were recorded in rotation frames of
0.5 per angular range of 90 followed by a continuous set of 90
for measured Friedel pairs in inverse beam geometry. All data sets
were integrated and scaled with the HKL package [38] and further
processed using programs from the CCP4 suite [39]. Data collection
statistics are shown in Table 1. One mercury position could be
confirmed in anomalous difference Patterson maps and was used
for initial phasing with MLPHARE [37]. Phases were improved by
solvent flattening and density modification. The experimental MAD
map had an overall figure of merit of 0.55 (Table 2) and allowed
tracing of most of the polypeptide chain, including side chains.
Examination of the packing indicated reasonable crystal contacts
between the riboflavin synthase monomers without overlap of sym-
metry-related molecules.
Figure 8. Proposed Active Site Dimer of S. pombe Riboflavin Syn- Model Building and Refinement
thase with Modeled Substrate 2 Model building was carried out with the program MAIN [40]. The
initial model was subjected to rigid body and positional refinementView along a pseudo-2-fold symmetry axis of the two barrel domains
of adjacent subunits. using CNS [41]. After several cycles of manual rebuilding, positional
Biosynthesis of Riboflavin Synthase
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Figure 9. Studies on the Reaction Mech-
anism
Stereo view of the active site residues formed
by two adjacent riboflavin synthase mono-
mers of S. pombe with bound 6-carboxyethyl-
7-oxo-8-ribityllumazine (A). The ligand bound
to the N barrel (red) is drawn in yellow,
whereas the 6-carboxyethyl-7-oxo-8-ribityl-
lumazine in the adjacent C barrel (blue) is
shown in dark yellow.
(B) Proposed binding of 6,7-dimethyl-8-ribi-
tyllumazine at the active site.
(C) Model for the pentacyclic reaction inter-
mediate 4 [8].
and B factor refinement and two rounds of simulated annealing two adjacent S. pombe riboflavin synthase monomers. This active
dimer was generated by superposition of S. pombe riboflavin syn-water molecules were incorporated automatically into the S. pombe
riboflavin synthase model at 2.1 A˚ resolution. The progress of all thase monomers on the crystal structure of the E. coli trimer (1I8D).
Correct atom types, stereocenters, hybridization states, and bondrefinement procedures was monitored by using 10% of the reflec-
tions to calculate a free R value (Rfree). A geometry check using types were defined, and Gasteiger-Hu¨ckel charges were assigned
to each atom. A spherical subset of 8 A˚ radius around compoundthe program PROCHECK [42] revealed that 86.0% and 14.0% of all
nonglycine residues lie within the most favored and additionally al- 4 was defined and energy minimized using the Powell method and
the Tripos force field. The remaining protein was treated as rigidlowed regions of the Ramachandran plot, respectively (Table 1) [43].
body during energy minimization.
Molecular Modeling
Using SYBYL modeling software [44], two substrate molecules, 6,7- Analysis and Graphical Representation
Stereochemical parameters were assessed with PROCHECK [42]. Pro-dimethyl-8-ribityllumazine (1) and the reaction intermediate 4, were
generated and modeled into the proposed active site formed by tein structures were aligned three-dimensionally by TOP3D [39], and
Table 2. MAD Data Statistics for the Hg Derivative (Thiomersal, DERI)
Figure of merit (FOM) 0.55
Remote Peak Edge
Wavelength (A˚) 0.94991 1.000 1.010
Phasing power
Iso (centric) — 1.23 (34) 0.72 (318)
Ano (acentric) — 0.89 (8499) 0.99 (8533)
RCullisa
Iso (centric) — 0.79 (311) 0.85 (318)
Iso (acentric) — 0.79 (8499) 0.83 (8533)
Ano 0.84 (8427) 0.75 (8399) 0.73 (8394)
a RCullis  hkl||FPH(hkl)|  |FP(hkl)||  FHcalc/hkl||FPH(hkl)|  |FP(hkl)||
The numbers in parentheses are given for the independent reflections.
Figure of merit value corresponds to an overall resolution shell of 19.88–2.5 A˚.
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superpositions were further refined with MAIN [40]. Structural figures 16. Rowan, T., and Wood, H.C.S. (1963). The biosynthesis of ribofla-
vin. Proc. Chem. Soc. (London), 21–22.were prepared with MOLSCRIPT [45], BOBSCRIPT [46], and RAST-
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